How to get URL link on X (Twitter) App
First, the background: every year the MP tasked with keeping an eye on the Bundeswehr – currently @EvaHoegl – visits German military facilities all over the world and chats to the troops about everything that’s bugging them, from cruddy gym equipment to bullying superiors. (2/x)
https://twitter.com/thetimes/status/1566009271569059840- Both said NATO should give Ukraine every kind of weapon it needs, up to and including modern western battle tanks and combat jets.
1. 🇩🇪 needs to "self-critically" examine why it was caught napping by the invasion of Ukraine. Klingbeil says some 🇱🇹 colleagues told him they were worried about a 🇷🇺 attack: "My first reflex was: Nonsense, Putin won't do that. But exactly this reflex was the mistake." /2
The vampires try to turn Granny Weatherwax into one of their own. But something odd happens: the vampires develop an irresistible hunger for sweet tea and biscuits instead of blood. Through sheer mental strength GW has reversed the direction of influence. /2
There is no sign that Germany will comply with Putin's ultimatum, even though Russia has explicitly said it will turn off the taps unless Gazprom and other state-owned energy companies receive payment in rubles. /2
Since the 1960s the Druzhba (“Friendship”) pipeline has carried oil from fields in Tatarstan to the PCK refinery, just on the German side of the border with Poland. Today it provides (I think) about a third of Germany’s total crude imports. /2
https://twitter.com/olivernmoody/status/1504365869056630785
Katrin Göring-Eckardt, Bundestag vice-president: "We see you. Your country has chosen democracy and that is exactly what Putin fears. He’s trying to cancel you’re existence but in this he has already failed … You are showing every day how strong your will to liberty is."
https://twitter.com/VictoriaPeckham/status/1371549098185273344First you had the low headline efficacy rate (compared to Pfizer), then the confusion over dosing, then the bizarre attempt to combine the efficacy rates for the two dosing schedules, then the junk interim efficacy data for over-65s - all of that increased the scrutiny /2